Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Evotec discontinues EVT-301 development following liver function findings

Sep. 18, 2006

Two-year data show treatment effect of Campath in MS

Sep. 18, 2006

NeuroMedix advances preclinical testing of Alzheimer's candidate Minozac

Sep. 18, 2006

Compounds with potential use in neurological disorders disclosed

Sep. 15, 2006

Plans for primate study of BrainStorm's Parkinson's disease stem cell therapy

Sep. 15, 2006

Tripos and CeNeS extend COMT inhibitor research agreement

Sep. 15, 2006

Enrollment under way in phase IIa safety study of NTx-265 in stroke

Sep. 15, 2006

Preliminary results from phase III study of CIP-Tramadol ER

Sep. 15, 2006

KKJA-0036: novel T-type calcium channel blocker is effective against visceral pain

Sep. 15, 2006

Recent Allergan and ACADIA patents report novel analgesic agents

Sep. 14, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...